Indefinite Delivery Contract 75N98026D00014
Award Date 5/4/26
Last Date to Order 5/3/36
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- The National Institute of Neurological Disorders and Stroke awarded an indefinite-delivery contract to Sri International on May 4, 2026, with a ceiling value of $49,999,999.00. This is one of multiple awards issued under the Drug Manufacturing and Formulation Program (DMFP), a component of the Blueprint Neurotherapeutics Network. The IDIQ carries no set-aside. Place of performance is not specified in the source. The contract supports the NINDS DRUG MANUFACTURING AND FORMULATION PROGRAM, which...
- The National Institute of Neurological Disorders and Stroke awarded a multiple-award Indefinite Delivery Contract to Curia Global Inc. (doing business as Amri) on May 4, 2026, with a $49,999,999 ceiling and ultimate completion date of May 3, 2036. The DMFP (Drug Manufacturing and Formulation Program) IDIQ supports the Blueprint Neurotherapeutics Network by enabling candidate molecules to enter clinical-stage development. The contract procures drug manufacturing and formulation services,...
- The National Institute of Neurological Disorders and Stroke awarded a multiple-award IDIQ to Alchem Laboratories Corporation on May 4, 2026, with a $49.999 million ceiling and an ultimate completion date of May 3, 2036. The contract supports the Drug Manufacturing and Formulation Program (DMFP), a component of the Blueprint Neurotherapeutics Network (BPN). The originating solicitation, posted May 3, 2024, sought drug manufacturing and formulation services to enable candidate molecules to enter...
- The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the Department of Health and Human Services, awarded an Indefinite Delivery Contract (IDC) with a ceiling value of $37,393,571 to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The IDC, titled the "Drug Manufacturing and Formulation Program (DMFP)," provides a broad range of pharmaceutical research and development...
- This indefinite delivery contract was awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Mriglobal, a 501(c)(3) not-for-profit research organization, with a potential value of $49,713,679. The contract is for Chemistry, Manufacturing and Controls (CMC) and related services to support the development of drug substances for the Division of Preclinical Innovation's translational research programs. The contract...
- The National Institutes of Health National Institute of Neurological Disorders and Stroke awarded an indefinite-delivery/indefinite-quantity multiple award contract to Battelle Memorial Institute for Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders. The original solicitation sought to procure manufacturing and nonclinical services over five years to support the development of biotechnology products for...
- The National Institute of Neurological Disorders and Stroke awarded an indefinite-delivery contract to Curia Global Inc. (doing business as Amri) on March 16, 2018, with a ceiling of $39.5 million and a single-award structure. The contract is not set-aside and extends through March 15, 2028. The IDIQ supports the Medicinal Chemistry Support Program for Therapeutic Development, procuring a broad range of pharmaceutical research and development services including medicinal chemistry, hit-to-lead...
- Mriglobal (doing business as Midwest Research Institute), a 501(c)(3) not-for-profit research organization based in Kansas City, Missouri, was awarded a single-award Indefinite Delivery Contract by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, on September 1, 2021. The contract carries a ceiling value of $545.5 million and extends through August 31, 2028, with no small business set-aside applied. The prime contractor delivers...
- The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), has awarded Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods, an Indefinite Delivery Contract (IDC) valued at $149.2 million. The purpose of this contract is to provide manufacturing and nonclinical studies support for the development of therapeutic biotechnology products for neurological-related disorders. Under this IDC, NINDS...
- This indefinite delivery contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke to Leidos, Inc. as a multiple award contract to provide manufacturing and nonclinical services in support of developing therapeutic biotechnology products for neurological-related disorders. Valued at up to $149.2 million, the contract has a performance period through September 2030. Under the master contract, Leidos...